Advertisement
Advertisement
November 17, 2026
Perfuze’s NeuroSheath 8-F Long Sheath Receives FDA Clearance
KEY TAKEAWAYS
- Perfuze has received FDA 510(k) clearance for NeuroSheath, an 8-F long sheath for neurovascular access.
- The device is designed to accommodate the Millipede88 superbore aspiration catheter, which has a 0.088-inch diameter.
- A limited United States market release is planned at select stroke centers, with broader availability expected in 2027.
November 17, 2026—Perfuze announced FDA 510(k) clearance for NeuroSheath, an 8-F long sheath designed for neurovascular access. The company will begin a limited market release of NeuroSheath at select United States stroke centers and full availability in the United States is expected in 2027, noted the press release.
The company stated that NeuroSheath completes Perfuze’s stroke thrombectomy system, from access through aspiration. It is sized to accommodate the company’s Millipede88 superbore aspiration catheter built on Perfuze’s Corrugated technology.
Sunil Sheth, MD, Director of Vascular and Interventional Neurology Division, Department of Neurology, UTHealth Houston in Houston, Texas, commented on the device in the Perfuze press release.
“NeuroSheath is designed to give our team the versatility and flexibility to use any size aspiration catheter we’d like, right up to a superbore 0.088-inch,” commented Dr. Sheth. “That way, the case decides the catheter, not the sheath. That’s what we’ve been looking for in a long sheath for neurovascular access.”
Advertisement
Advertisement